Pages that link to "Q37853359"
Jump to navigation
Jump to search
The following pages link to Efficacy of biological therapies in inflammatory bowel disease: systematic review and meta-analysis (Q37853359):
Displaying 50 items.
- Vedolizumab for the treatment of ulcerative colitis and Crohn's disease (Q24630083) (← links)
- Ustekinumab for the treatment of Crohn's disease: can it find its niche? (Q26771890) (← links)
- A Systematic Review of the Cost-Effectiveness of Biologics for the Treatment of Inflammatory Bowel Diseases (Q26775384) (← links)
- Nanomedicine and drug delivery strategies for treatment of inflammatory bowel disease (Q26777400) (← links)
- Advances in refractory ulcerative colitis treatment: A new therapeutic target, Annexin A2 (Q26798299) (← links)
- Optimization of the treatment with immunosuppressants and biologics in inflammatory bowel disease (Q26866940) (← links)
- Review article: anti-adhesion therapies for inflammatory bowel disease (Q26999705) (← links)
- Inflammatory pathways of importance for management of inflammatory bowel disease (Q27005445) (← links)
- Treating beyond symptoms with a view to improving patient outcomes in inflammatory bowel diseases (Q27008246) (← links)
- Redeeming an old foe: protective as well as pathophysiological roles for tumor necrosis factor in inflammatory bowel disease (Q27027630) (← links)
- An indirect comparison of infliximab versus adalimumab or golimumab for active ulcerative colitis (Q28079322) (← links)
- Systematic review: treatment pattern and clinical effectiveness and safety of pharmaceutical therapies for Crohn's disease in Europe (Q28080300) (← links)
- Cytokines, IBD, and colitis-associated cancer (Q28080901) (← links)
- IBS-like symptoms in patients with ulcerative colitis (Q28088663) (← links)
- Risk of Biologic Therapy-Associated Progressive Multifocal Leukoencephalopathy: Use of the JC Virus Antibody Assay in the Treatment of Moderate-to-Severe Crohn's Disease (Q28538974) (← links)
- Strategies for the prevention of postoperative recurrence of Crohn's disease (Q31122078) (← links)
- Biological treatment of Crohn's disease (Q33354991) (← links)
- Anti-TNF alpha in the treatment of ulcerative colitis: a valid approach for organ-sparing or an expensive option to delay surgery? (Q33564081) (← links)
- Retrospective cohort study of anti-tumor necrosis factor agent use in a veteran population (Q33667897) (← links)
- Evaluation of the Cross-reactivity of Antidrug Antibodies to CT-P13 and Infliximab Reference Product (Remicade): An Analysis Using Immunoassays Tagged with Both Agents (Q33726030) (← links)
- Predicting Pre-emptive Discussions of Biologic Treatment: Results from an Openness and Preference Survey of Inflammatory Bowel Disease Patients and Their Prescribers (Q33844419) (← links)
- Postprandial response of bone turnover markers in patients with Crohn's disease (Q33948406) (← links)
- Medical management of Crohn's disease. (Q34046139) (← links)
- Clinical use of anti-TNF therapy and increased risk of infections (Q34338096) (← links)
- A medicoeconomic review of early intervention with biologic agents in the treatment of inflammatory bowel diseases (Q34353032) (← links)
- Serial intralesional injections of infliximab in small bowel Crohn's strictures are feasible and might lower inflammation (Q34418894) (← links)
- Vitamin D deficiency in patients with intestinal malabsorption syndromes--think in and outside the gut. (Q34491388) (← links)
- Comparative efficacy of pharmacologic interventions in preventing relapse of Crohn's disease after surgery: a systematic review and network meta-analysis (Q34758714) (← links)
- Tumor necrosis factor-α antibodies (infliximab, adalimumab and certolizumab) in Crohn's disease: systematic review and meta-analysis (Q35052356) (← links)
- Stimulation of duodenal biopsies and whole blood from dogs with food-responsive chronic enteropathy and healthy dogs with Toll-like receptor ligands and probiotic Enterococcus faecium (Q35165968) (← links)
- The th17/treg immune balance in ulcerative colitis patients with two different chinese syndromes: dampness-heat in large intestine and spleen and kidney yang deficiency syndrome (Q35177977) (← links)
- Infliximab to treat Crohn's disease: an update. (Q35304737) (← links)
- Managing refractory Crohn's disease: challenges and solutions (Q35460367) (← links)
- PRISMA--efficacy and safety of vedolizumab for inflammatory bowel diseases: a systematic review and meta-analysis of randomized controlled trials (Q35530872) (← links)
- Management of perianal fistulas in Crohn's disease: an up-to-date review (Q35558085) (← links)
- From historical perspectives to modern therapy: a review of current and future biological treatments for Crohn's disease (Q35559305) (← links)
- Crotoxin from Crotalus durissus terrificus is able to down-modulate the acute intestinal inflammation in mice. (Q35597581) (← links)
- Adverse symptoms with anti-TNF-alpha therapy in inflammatory bowel disease: systematic review and duration-response meta-analysis (Q35645531) (← links)
- Select a suitable treatment strategy for Crohn's disease: step-up or top-down. (Q35721537) (← links)
- Systematic review with meta-analysis: faecal diversion for management of perianal Crohn's disease. (Q35743069) (← links)
- Enterocutaneous fistula as early presentation of Crohn's disease in an adult woman (Q35757538) (← links)
- MR enterography to evaluate sub-clinical intestinal inflammation in children with spondyloarthritis (Q35797727) (← links)
- Diterpenoid alkaloids of Aconitum laciniatum and mitigation of inflammation by 14-O-acetylneoline in a murine model of ulcerative colitis. (Q35913346) (← links)
- A Saudi Gastroenterology association position statement on the use of tumor necrosis factor-alfa antagonists for the treatment of inflammatory bowel disease (Q35973766) (← links)
- Short-Term Surveillance of Cytokines and C-Reactive Protein Cannot Predict Efficacy of Fecal Microbiota Transplantation for Ulcerative Colitis (Q36062250) (← links)
- Tumour necrosis factor-α inhibition can stabilize disease in progressive vitiligo. (Q36094915) (← links)
- Angioedema associated with Crohn's disease: response to biologics. (Q36233882) (← links)
- Extracolonic Cancer in Inflammatory Bowel Disease: Data from the GETECCU Eneida Registry. (Q36378458) (← links)
- Efficacy of infliximab in acute severe ulcerative colitis: a single-centre experience (Q36637710) (← links)
- Promising effect of Magliasa, a traditional Iranian formula, on experimental colitis on the basis of biochemical and cellular findings (Q36731168) (← links)